IJCM  Vol.10 No.10 , October 2019
Exosomes in Sepsis Diagnosis and Treatment
Abstract: Sepsis has been redefined as a disorder of host response to infection, systemic circulation and cell/metabolic abnormalities. Exosomes are small (30 - 150 nm) vesicles produced by all cells under physiological and pathological conditions, with the potential to transfer proteins, lipids, small RNAs, messenger RNAs, or DNA between cells. Exosomes are natural cargoes for proteins, carbohydrates, nucleic acids and lipids. Exosomes play a central role in cellular communication and contribute to many pathophysiological processes, including immune responses and tumor progression. Exosomes have made great progress in many subject areas, and their potential role in sepsis is now being explored. In this review, several topics are mentioned. Firstly, we discuss the biological characteristics and functions of exosomes. Next, we focus on the diagnostic and therapeutic potential of exosomes in sepsis. Finally, we discuss some of the problems encountered by the current exosomes research institute. Therefore, the exosomes with combined diagnostic and therapeutic functions play a huge clinical application for the future research in sepsis.
Cite this paper: Huang, M. , Deng, H. , Li, J. , Tao, X. and Jia, B. (2019) Exosomes in Sepsis Diagnosis and Treatment. International Journal of Clinical Medicine, 10, 565-575. doi: 10.4236/ijcm.2019.1010046.

[1]   Yanez-Mo, M., Siljander, P.R., Andreu, Z., et al. (2015) Biological Properties of Extracellular Vesicles and Their Physiological Functions. Journal of Extracellular Vesicles, 4, 27065-27066.

[2]   De Toro, J., Herschlik, L., Waldner, C., et al. (2015) Emerging Roles of Exosomes in Normal and Pathological Conditions: New Insights for Diagnosis and Therapeutic Applications. Frontiers in Immunology, 6, 203.

[3]   Manu, S., Gary, S.P., Mitchell, L.L., et al. (2016) Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 762-774.

[4]   Terrasini, N. and Lionetti, V. (2017) Exosomes in Critical Illness. Critical Care Medicine, 45, 1054-1060.

[5]   Johnstone, R.M., Adam, M., Hammond, J.R., et al. (1987) Vesicle Formation during Reticulocyte Maturation—Association of Plasma-Membrane Activities with Released Vesicles (Exosomes). Journal of Biological Chemistry, 262, 9412-9420.

[6]   Buschow, S.I., Nolte-’T Hoen, E.N.M., van Niel, G., et al. (2009) MHC II in Dendritic Cells Is Targeted to Lysosomes or T Cell-Induced Exosomes via Distinct Multivesicular Body Pathways. Traffic, 10, 1528-1542.

[7]   Shahabipour, F., Barati, N., Johnston, T.P., et al. (2017) Exosomes: Nanoparticulate Tools for RNA Interference and Drug Delivery. Journal of Cellular Physiology, 232, 1660-1668.

[8]   Ren, J., He, W., Zheng, L., et al. (2016) From Structures to Functions: Insights into Exosomes as Promising Drug Delivery Vehicles. Biomaterials Science, 4, 910-921.

[9]   Valadi, H., Ekstrom, K., Bossios, A., et al. (2007) Exosome-Mediated Transfer of mRNAs and microRNAs Is a Novel Mechanism of Genetic Exchange between Cells. Nature Cell Biology, 9, 654-672.

[10]   Lucia, P., Andrea, Z. and Annalisa, R. (2018) Biophysical Properties of Extracellular Vesicles in Diagnostics. Biomarkers in Medicine, 12, 383-391.

[11]   Wu, J., Wang, Y. and Li, L. (2017) Functional Significance of Exosomes Applied in Sepsis: A Novel Approach to Therapy. Biochimica et Biophysica Acta—Molecular Basis of Disease, 1863, 292-297.

[12]   Srinivasan, S., Vannberg, F.O. and Dixon, J.B. (2016) Lymphatic Transport of Exosomes as a Rapid Route of Information Dissemination to the Lymph Node. Scientific Reports, 6, Article No. 24436.

[13]   Conlan, R.S., Pisano, S., Oliveira, M.I., et al. (2017) Exosomes as Reconfigurable Therapeutic Systems. Trends in Molecular Medicine, 23, 636-650.

[14]   Takahashi, A., Okada, R., Nagao, K., et al. (2017) Exosomes Maintain Cellular Homeostasis by Excreting Harmful DNA from Cells. Nature Communications, 8, 15287.

[15]   Pierre, R., Johannes, Z. and Susanne, D. (2018) Extracellular Vesicles as Markers and Mediators in Sepsis. Theranostics, 8, 3348-3365.

[16]   Gambim, M.H., Do Carmo, A.D.O., Marti, L., et al. (2007) Platelet-Derived Exosomes Induce Endothelial Cell Apoptosis through Peroxynitrite Generation: Experimental Evidence for a Novel Mechanism of Septic Vascular Dysfunction. Critical Care, 11, R107.

[17]   Revenfeld, A.L.S., Baek, R., Nielsen, M.H., et al. (2014) Diagnostic and Prognostic Potential of Extracellular Vesicles in Peripheral Blood. Clinical Therapeutics, 36, 830-846.

[18]   Juliana, M.R., Ludmila, R.P.F., Gustavo, H.E., et al. (2018) Exosomes from Patients with Septic Shock Convey miRNAs Related to Inflammation and Cell Cycle Regulation: New Signaling Pathways in Sepsis? Critical Care (London, England), 22, 68.

[19]   Wu, S., Yang, J.C., Rau, C., et al. (2013) Profiling Circulating microRNA Expression in Experimental Sepsis Using Cecal Ligation and Puncture. PLoS ONE, 8, e77936.

[20]   Jia, P., Wu, X., Dai, Y., et al. (2017) MicroRNA-21 Is Required for Local and Remote Ischemic Preconditioning in Multiple Organ Protection against Sepsis. Critical Care Medicine, 45, E703-E710.

[21]   Song, Y., Dou, H., Li, X., et al. (2017) Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1-Primed Mesenchymal Stem Cells against Sepsis. Stem Cells, 35, 1208-1221.

[22]   Cao, X.H., et al. (2019) MiR-145 Negatively Regulates TGFBR2 Signaling Responsible for Sepsis-Induced Acute Lung Injury. Biomedicine & Pharmacotherapy, 111, 852-858.

[23]   Ebru, K., Steffen, U.E., Julia, H., et al. (2018) Extracellular Vesicles: Packages Sent with Complement. Frontiers in Immunology, 9, 721.

[24]   Schmoch, T., et al. (2017) New Sepsis-3 Definition: Do We Have to Treat Sepsis before We Can Diagnose It from Now on? Der Anaesthesist, 66, 614-621.

[25]   Zhu, Y., Feng, X., Abbott, J., et al. (2014) Human Mesenchymal Stem Cell Microvesicles for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice. Stem Cells, 32, 116-125.

[26]   Masson, S., Caironi, P., Fanizza, C., et al. (2016) Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements during Albumin Replacement in Patients with Severe Sepsis or Septic Shock. Critical Care Medicine, 44, 707-716.

[27]   Zhou, Y., et al. (2018) Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis. Molecular Therapy: The Journal of the American Society of Gene Therapy, 26, 1375-1384.

[28]   Chen, H., Lai, P., Lan, Y., et al. (2014) Exosomal ATF3 RNA Attenuates Pro-Inflammatory Gene MCP-1 Transcription in Renal Ischemia-Reperfusion. Journal of Cellular Physiology, 229, 1202-1211.

[29]   Hyungsoon, I., Cesar, M.C., et al. (2018) New Technologies for Analysis of Extracellular Vesicles. Chemical Reviews, 118, 1917-1950.

[30]   Lotvall, J., Hill, A.F., Hochberg, F., et al. (2014) Minimal Experimental Requirements for Definition of Extracellular Vesicles and Their Functions: A Position Statement from the International Society for Extracellular Vesicles. Journal of Extracellular Vesicles, 3, 26913.

[31]   Barile, L. and Vassalli, G. (2017) Exosomes: Therapy Delivery Tools and Biomarkers of Diseases. Pharmacology & Therapeutics, 174, 63-78.

[32]   Angus, D.C. and van der Poll, T. (2013) Severe Sepsis and Septic Shock. The New England Journal of Medicine, 369, 2063.

[33]   Wang, X.L., et al. (2015) miR-15a/16 Are Upreuglated in the Serum of Neonatal Sepsis Patients and Inhibit the LPS-Induced Inflammatory Pathway. International Journal of Clinical and Experimental Medicine, 8, 5683-5690.

[34]   Hsieh, C.-H., et al. (2012) Whole Blood-Derived microRNA Signatures in Mice Exposed to Lipopolysaccharides. Journal of Biomedical Science, 19, Article No. 69.

[35]   Wu, S.C., Yang, J.C., Rau, C.S., Chen, Y.C., Lu, T.H., et al. (2013) Profiling Circulating microRNA Expression in Experimental Sepsis Using Cecal Ligation and Puncture. PLoS ONE, 8, e77936.

[36]   Rebecca, E.B., Daniel, J.C., Lindsey, R., et al. (2016) Anti-Inflammatory Effects of miR-21 in the Macrophage Response to Peritonitis. Journal of Leukocyte Biology, 99, 361-371.

[37]   Christoph, R., Mark, L., David, V.C., et al. (2013) Circulating microRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis. PLoS ONE, 8, e54612.

[38]   Wang, H.J., Zhang, P.J., Chen, W.J., Feng, D., Jia, Y.H. and Xie, L.X. (2012) Four Serum microRNAs Identified as Diagnostic Biomarkers of Sepsis. The Journal of Trauma and Acute Care Surgery, 73, 850-854.

[39]   Tanaporn, P., Wiwat, C., Poorichaya, S., et al. (2017) Urinary Exosomal Activating Transcriptional Factor 3 as the Early Diagnostic Biomarker for Sepsis-Induced Acute Kidney Injury. BMC Nephrology, 18, 10.

[40]   Xu, Y., Ku, X., Wu, C., Cai, C., Tang, J. and Yan, W. (2018) Exosomal Proteome Analysis of Human Plasma to Monitor Sepsis Progression. Biochemical and Biophysical Research Communications, 499, 856-861.

[41]   Zhu, D., Pan, C., Li, L., et al. (2013) MicroRNA-17/20a/106a Modulate Macrophage Inflammatory Responses through Targeting Signal-Regulatory Protein α. The Journal of Allergy and Clinical Immunology, 132, 426-436.e8.

[42]   Luciano, C.P.A., Mariano, J., Vera, P., et al. (2007) Platelet-Derived Exosomes from Septic Shock Patients Induce Myocardial Dysfunction. Critical Care (London, England), 11, R120.

[43]   Wang, X., Gu, H., Qin, D., et al. (2015) Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis. Scientific Reports, 5, Article No. 13721.

[44]   Miksa, M., Wu, R., Dong, W., Das, P., Yang, D. and Wang, P. (2006) Dendritic Cell-Derived Exosomes Containing Milk Fat Globule Epidermal Growth Factor-Factor VIII Attenuate Proinflammatory Responses in Sepsis. Shock, 25, 586-593.

[45]   Chang, C.L., Sung, P.H., Chen, K.H., et al. (2018) Adipose-Derived Mesenchymal Stem Cell-Derived Exosomes Alleviate Overwhelming Systemic Inflammatory Reaction and Organ Damage and Improve Outcome in Rat Sepsis Syndrome. American Journal of Translational Research, 10, 1053-1070.